The rice protein formula is available without a prescription. It can be used as an alternative to widely hydrolyzed formulations (EHF) or soy protein formulations.

Market Analysis and Insights: Global Rice Protein Based Infant Formula Market
The global Rice Protein Based Infant Formula market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Rice Protein Based Infant Formula Scope and Market Size
The global Rice Protein Based Infant Formula market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rice Protein Based Infant Formula market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Non-GMO Infant Formula
GMO Infant Formula

Segment by Application
0-6 Months
6-12 Months
1-3 Years

The Rice Protein Based Infant Formula market is analysed and market size information is provided by regions (countries). Segment by Application, the Rice Protein Based Infant Formula market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Bayer
Biolab
Lactalis International
Kate Farms
La Mandorle
Laboratorios Ordesa
Nucitec